[CBAY] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[CBAY] CymaBay Therapeutics, Inc.
Announcement Date
05-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- -9.34%
YoY- -41.58%
Quarter Report
CBAY's Result
CBAY's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -10,726 -13,088 -29,413 -26,282 -24,038 -23,075 -19,449 -32.77%
Tax -614 -768 -150 1,425 1,610 1,176 1,106 -
NP -10,726 -13,088 -29,413 -26,282 -24,038 -23,075 -19,449 -32.77%
Tax Rate - - - - - - - -
Total Cost 10,726 13,088 29,413 26,282 24,038 23,075 19,449 -32.77%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS -0.16 -0.19 -0.43 -0.38 -0.35 -0.37 -0.31 -35.68%
EPS Diluted -0.16 -0.19 -0.43 -0.38 -0.35 -0.37 -0.31 -35.68%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.